Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells

Molecular Cancer Therapeutics

Volumn 2, Issue 8, 2003, Pages 797-803

  Thompson, Todd A ^a   Wilding, George ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2,5,7,8 PENTAMETHYL 1 HYDROXYCHROMAN; 2,2,5,7,8-PENTAMETHYL-1-HYDROXYCHROMAN; ALPHA TOCOPHEROL; ANTIANDROGEN; ANTIOXIDANT; CHROMAN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CELL CULTURE; HUMAN; MALE; PROSTATE TUMOR;

ANDROGEN ANTAGONISTS; ANTIOXIDANTS; CHROMANS; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 2342573753     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lamb, D. J., Weigel, N. L., and Marcelli, M. Androgen receptors and their biology. Vitam. Horm., 62: 199-229, 2001.
2. Wilding, G. The importance of steroid hormones in prostate cancer. Cancer Surv., 14: 113-130, 1992.
3. Wilding, G. Endocrine control of prostate cancer. Cancer Surv., 23:43-62, 1995.
4. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics, 2003. CA Cancer J. Clin., 53: 5-26, 2003. (Pubitemid 36163619)
5. Gronberg, H. Prostate cancer epidemiology. Lancet, 361: 859-864, 2003. (Pubitemid 36331852)
6. Evans, H. M., and Bishop, K. S. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science (Wash. DC), 56:650-651, 1922.
7. Brigelius-Flohe, R., and Traber, M. G. Vitamin E: function and metabolism. FASEB J., 13: 1145-1155, 1999. (Pubitemid 29300361)
8. Burton, G. W., and Traber, M. G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu. Rev. Nutr., 10: 357-382, 1990.
9. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983. (Pubitemid 13122588)
10. Ripple, M. O., Henry, W. F., Rago, R. P., and Wilding, G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl. Cancer Inst. (Bethesda), 89: 40-48, 1997. (Pubitemid 26428076)
11. Riegman, P. H., Vlietstra, R., J., van der Korput, J. A., Brinkmann, A. O., and Trapman, J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol., 5:1921-1930, 1991.
12. Young, C. Y., Montgomery, B. T., Andrews, P. E., Qui, S. D., Bilhartz, D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
13. Warriar, N., Page, N., Koutsilieris, M., and Govindan, M. V. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Prostate, 24: 176-186, 1994. (Pubitemid 24122066)
14. Veldscholte, J., Berrevoets, C. A., and Mulder, E. Studies on the human prostatic cancer cell line LNCaP. J. Steroid Biochem. Mol. Biol., 49: 341-346, 1994. (Pubitemid 24240620)
15. Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., and Sawyers, C. L. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med., 3: 402-408, 1997. (Pubitemid 27145681)
16. Israel, K., Sanders, B. G., and Kline, K. RRR-α-tocopherol succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr. Cancer, 24: 161-169, 1995.
17. Venkateswaran, V., Fleshner, N. E., and Klotz, L. H. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J. Urol., 168: 1578-1582, 2002. (Pubitemid 35034193)
18. Ni, J., Chen, M., Zhang, Y., Li, R., Huang, J., and Yeh, S. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem. Biophys. Res. Commun., 300: 357-363, 2003. (Pubitemid 38375816)
19. Gunawardena, K., Murray, D. K., and Meikle, A. W. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate, 44: 287-295, 2000.
20. Israel, K., Yu, W., Sanders, B. G., and Kline, K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr. Cancer, 36: 90-100, 2000. (Pubitemid 30317840)
21. Zhang, Y., Ni, J., Messing, E. M., Chang, E., Yang, C. R., and Yeh, S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc. Natl. Acad. Sci. USA, 99: 7408-7413, 2002. (Pubitemid 34568704)
22. Wilding, G., Chen, M., and Gelmann, E. P. Aberrant response in vitroof hormone-responsive prostate cells to antiandrogens. Prostate, 14:103-115, 1989. (Pubitemid 19154802)
23. Rago, R., Mitchen, J., and Wilding, G. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal. Biochem., 191: 31-34, 1990.
24. Thompson, T. A., Gould, M. N., Burkholder, J. K., and Yang, N-S. Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell. Dev. Biol., 29A: 165-170, 1992. (Pubitemid 23102585)
25. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173:534-540, 1990.
26. Lieberman, R. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development. Urology, 58: 83-90, 2001. (Pubitemid 32743418)
27. Nakamura, K., Yasunaga, Y., Segawa, T., Ko, D., Moul, J. W., Srivastava, S., and Rhim, J. S. Curcumin down-regulates AR gene expression and activation in prostate cancer cells. Int. J. Oncol., 21: 825-830, 2002.
28. Le, H. T., Schaldach, C. M., Firestone, G. L., and Bjeldanes, L. F. Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J. Biol. Chem., 278: 21136-21145, 2003. (Pubitemid 36806427)
29. Burton, G. W., Cheeseman, K. H., Doba, T., Ingold, K. U., and Slater, T. F. Vitamin E as an antioxidant in vitro and in vivo. In: Biology of Vitamin E: Ciba Foundation Symposium 101, pp. 4-18. London: Pitman, 1983.
30. Dimitrov, N. V., Meyer, C., Gilliland, D., Ruppenthal, M., Chenoweth, W., and Malone, W. Plasma tocopherol concentrations in response to supplemental vitamin E. Am. J. Clin. Nutr., 53: 723-729, 1991. (Pubitemid 21917647)
31. Traber, M. G., Elsner, A., and Brigelius-Flohe, R. Synthetic as compared with natural vitamin E is preferentially excreted as αCEHC in human urine: studies using deuterated α-tocopheryl acetates. FEBS Lett., 437:145-148, 1998. (Pubitemid 28498258)